Professor, Michigan State University
Managing Director, D.E. Shaw and Co., L.P.
Co-Founder and CEO, DNAnexus
Professor of Systems Biology, Columbia University
Co-Founder, BuddyTV
Professor, Michigan State University
Invenra, a Madison, WI-based startup that develops therapeutic antibodies for pharmaceutical companies and other clients, has raised more than $7.1 million from investors, according to a regulatory filing.
Twenty-three investors participated in the equity funding round, according to the... Read more »
[Updated 10/19/18, 5:08 pm. See below.] Rumors of a Boston adtech sale, a top-level departure at IBM’s Watson Health business, more cash to boost A.I. startups, and Boeing backing a space propulsion company dominate the Boston-area’s tech headlines from... Read more »
Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO.
The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced... Read more »
Two new battlegrounds emerged this week in the nation’s ongoing drug pricing debate. The first involved television: The federal government hopes that blaring prices in TV ads will essentially pressure drug makers into lowering them, and the pharma lobby fired back.... Read more »
LogicBio Therapeutics has joined the list of biotechs to go public this year but it had to cut the price of its IPO and sell more shares to pull it off.
The Cambridge, MA, biotech priced its offering of 7 million... Read more »
The race to get driverless cars on the road is a global endeavor, and one nation putting its pedal to the metal is Israel. A host of Israeli companies are working to develop the technologies that help these vehicles function properly,... Read more »
Austin—RealSavvy, a customizable online service that enables real estate brokers and agents to communicate with potential clients, is taking a $2.5 million round of financing that the company will repay in payments based on its monthly revenue.
Timia Capital is... Read more »
Exact Sciences has gone from being a customer of Biomatrica, a San Diego-based vendor of equipment for storing and preserving blood and saliva samples, to now being the company’s owner.
Madison, WI-based Exact (NASDAQ: EXAS), which is developing diagnostic tests... Read more »
Novartis has agreed to pay $2.1 billion cash to acquire Endocyte, expanding an ongoing effort by the Swiss firm to develop targeted radiation treatments for cancer.
Under the agreement, Novartis (NYSE: NVS) will pay shareholders of West Lafayette, IN-based... Read more »
Merck could soon join rival Bristol-Myers Squibb in making immunotherapy an option for kidney cancer patients who have never had treatment before.
Merck (NYSE: MRK) reported today that its blockbuster drug pembrolizumab (Keytruda) has hit its marks much earlier than... Read more »
AbbVie is positioning itself to add fibrosis drugs to its pipeline through a new research and development partnership with startup Morphic Therapeutics.
Under the agreement, AbbVie (NYSE: ABBV) will pay Morphic $100 million up front for exclusive options to license... Read more »
Codelicious, the Indianapolis-based educational tech startup, is on a mission to create access and remove barriers to teaching and learning computer science, says CEO Christine McDonnell.
Over the summer, the organization raised nearly $1 million from Collina Ventures, GRE... Read more »
Enterprise planning software company Anaplan pulled off its IPO in the middle of a broad market slump last week—raising $263.5 million—and its 43 percent share price surge on the first day of trading continues to hold while Nasdaq and the Dow... Read more »
In 2011, Silicon Valley investor Marc Andreessen penned a widely read essay declaring that “software is eating the world.” If he were to write an updated version today, it might proclaim that machine learning is eating the world.
Advances in data... Read more »
Applied Systems, a Chicago-area company that sells its cloud-based software to groups in the insurance industry, announced Wednesday that it has acquired Dynamis Software. West Allis, WI-based Dynamis develops software that insurance brokers and agents can use to compare the different... Read more »
The scientific interests of the late Microsoft co-founder Paul Allen led him to fund a pair of major research centers in the Boston area devoted to cracking mysteries of the human biological code—and aiming to recreate the sort of foundational work... Read more »
[Updated 10/17/18, 2:52 p.m. See below.] Express Scripts has just exerted its influence over the emerging market battle between drug makers trying to sell a new class of migraine-preventing medicines. The pharmacy benefits manager (PBM) is excluding a new... Read more »
Austin—Icon Technology, a company that builds 3D-printed homes and was permitted to construct its first home in Austin, TX, earlier this year, has closed a $9 million seed round of funding.
The company plans to use some of the money... Read more »
The inventor and developer of a drug, nusinersen (Spinraza), are among the winners of the Breakthrough Prize in Life Sciences. Adrian Krainer (pictured) of Cold Spring Harbor Laboratory and Frank Bennett, senior vice president of research at Ionis Pharmaceuticals, share the... Read more »
Gener8tor went north of the border to find some of the participants in its latest Wisconsin startup accelerator program.
The organization, which trains entrepreneurs and invests in some of the companies they run, appears to have picked two startups headquartered in... Read more »
Security-tech company Cybereason is announcing another boon flowing from close ties with its biggest investor, Japanese telecom and tech giant SoftBank. Boston-based Cybereason has formed a partnership with Arm, the dominant developer of computer chip architecture, which was acquired by SoftBank in... Read more »
Origin Code Academy, one of San Diego’s few coding schools—for-profit companies that offer short-term vocational training in computer programming—said this month it will shutter on Nov. 16 after about three years in business.
The company opened in late 2015, offering a... Read more »
Robust ecosystem supports tech hub and startup community
Wisconsin Economic Development Corporation
Founder and CEO, Lighter Capital
Managing Director, DaggerBoard Advisors
CEO, FullContact
VP of Research & Policy, Ewing Marion Kauffman Foundation
CEO and Fund Manager, Renaissance Venture Capital Fund
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
